RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $428,627 | $418,778 | $414,734 | $424,566 |
| % Growth | 2.4% | 1% | -2.3% | – |
| Cost of Goods Sold | $423,851 | $420,562 | $140,314 | $249,056 |
| Gross Profit | $4,776 | -$1,784 | $274,420 | $175,510 |
| % Margin | 1.1% | -0.4% | 66.2% | 41.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5,403 | -$11,068 | $266,403 | $156,821 |
| Operating Expenses | -$5,403 | -$11,068 | $266,403 | $156,821 |
| Operating Income | $10,179 | $9,284 | $8,017 | $18,689 |
| % Margin | 2.4% | 2.2% | 1.9% | 4.4% |
| Other Income/Exp. Net | $877 | $911 | $1,169 | $1,563 |
| Pre-Tax Income | $11,056 | $10,195 | $9,186 | $20,252 |
| Tax Expense | $669 | $2,833 | $1,863 | $5,395 |
| Net Income | $9,930 | $7,007 | $7,135 | $14,036 |
| % Margin | 2.3% | 1.7% | 1.7% | 3.3% |
| EPS | 0.07 | 0.05 | 0.055 | 0.11 |
| % Growth | 40% | -9.1% | -50% | – |
| EPS Diluted | 0.07 | 0.05 | 0.055 | 0.11 |
| Weighted Avg Shares Out | 140,140 | 140,140 | 129,727 | 128,771 |
| Weighted Avg Shares Out Dil | 140,140 | 140,140 | 129,727 | 128,771 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,559 | $1,682 | $2,098 | $2,455 |
| Interest Expense | $797 | $793 | $878 | $942 |
| Depreciation & Amortization | $14,930 | $14,777 | $14,602 | $16,984 |
| EBITDA | $26,783 | $25,765 | $24,666 | $38,178 |
| % Margin | 6.2% | 6.2% | 5.9% | 9% |